Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Recursion Pharmaceuticals Inc (RXRX) vs Wells Fargo & Co (WFC) Price & Performance

Recursion Pharmaceuticals IncTrade
Wells Fargo & CoTrade

Price performance (Past 24H)

Key statistics

Recursion Pharmaceuticals Inc vs Wells Fargo & Co — how do they compare? Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B), while Wells Fargo & Co trades at $87.35 (market cap $264.66B). The key difference: Wells Fargo & Co is far larger — about 146.2× Recursion Pharmaceuticals Inc's market cap, and Wells Fargo & Co pays a 2.29% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

RXRXWFC
Market Cap
$1.81B$264.66B
Sector
HealthFinancials
52-Week High
$6.79$96.40
52-Week Low
$2.84$73.42
Enterprise Value
$1.33B
Dividend Yield
2.29%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX

About Wells Fargo & Co

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.

Read more on WFC